April 26th, 2021 – Preparing for Process Improvements: Discussions of the Cell Therapy Industry’s Supply Chain, Automation, and Control Needs
April 26, 2021
BioProcess International
Related News
-
April 18, 2024Cellares Launches Cell Q, the World’s First Automated cGMP QC Workcell for Cell Therapies, to Resolve Manual QC Processing Bottleneck and Extend IDMO Capabilities from Manufacturing Through Quality Control
-
March 26, 2024
Christi Shaw, Former CEO of Kite, a Gilead Company, Appointed to Cellares Advisory Board to Advance Cell Therapy Manufacturing
-
March 12, 2024
Cellares Unveils First cGMP Compliant Cell Shuttle in its South San Francisco Center of Excellence
